Diagnosis and Management of Hereditary Angioedema

Clinical Significance of Low C4A

A low plasma C4A level primarily indicates C1 inhibitor (C1INH) deficiency and requires immediate measurement of C1INH antigen and functional levels to distinguish between hereditary angioedema (HAE) types I and II versus acquired C1INH deficiency, as recommended by the American Academy of Allergy, Asthma, and Immunology 1, 2
Low C4 serves as an excellent screening tool for C1INH deficiency states, with at least 95% of patients with C1INH deficiency demonstrating reduced C4 levels even between attacks, increasing to virtually 100% during active angioedema episodes, according to the American College of Allergy, Asthma, and Immunology 1, 3, 4

When C4A is low, measure C1INH antigen and functional levels immediately to determine the specific type of deficiency, as suggested by the European Academy of Allergy and Clinical Immunology 1, 2
Ensure timely laboratory processing, as C4 samples must be sent to the laboratory promptly to avoid artificially low results due to degradation, as recommended by the American Academy of Allergy, Asthma, and Immunology 1, 4

Type I HAE (85% of cases) is characterized by low C4 + low C1INH antigen + low C1INH function (<50-60% of lower limit of normal), according to the World Allergy Organization 5, 2
Type II HAE is characterized by low C4 + normal C1INH antigen + low C1INH function, as defined by the European Academy of Allergy and Clinical Immunology 5, 2
Acquired C1INH deficiency is characterized by low C4 + low C1INH antigen/function + low C1q levels, which distinguishes it from hereditary forms, as recommended by the American College of Allergy, Asthma, and Immunology 5, 2

Discontinue ACE inhibitors or ARBs immediately if the patient is taking these medications, as they are contraindicated in C1INH deficiency, according to the American Heart Association 1, 3, 4
Traditional therapies (epinephrine, antihistamines, corticosteroids) are ineffective for C1INH deficiency-related angioedema, as stated by the American Academy of Allergy, Asthma, and Immunology 1, 4
Contact system medications (icatibant, ecallantide) may be useful for acute attacks, as suggested by the European Academy of Allergy and Clinical Immunology 1, 4

Do not rely on C4 alone during treatment, as C4 levels can normalize in patients already receiving therapy for HAE, requiring repeat testing during an attack, as recommended by the World Allergy Organization 5, 2
Do not assume normal C4 excludes HAE, as HAE with normal C1INH levels exists as a separate entity diagnosed by exclusion, according to the American College of Allergy, Asthma, and Immunology 1, 3